Policy & Medicine

Former Sandoz/Novartis AG Executive Pleads Guilty to Price Fixing

Thomas Sullivan Apr 3, 2020 0

In February 2020, former senior Sandoz/Novartis AG executive Hector Armando Kellum pled guilty for his role in a conspiracy to fix prices, rig bids, and allocate customers for generic drugs. According to the Information, from at least March 2013 until at least June 2015, Kellum’s participation in the conspiracy affected products including…

When Money and Doritos Don’t Suffice – The…

Thomas Sullivan Oct 12, 2019 0

The Chaos Over Drug Compounding Continues As Judge Throws…

Thomas Sullivan Sep 17, 2019 0

Former Sandoz/Novartis AG Executive Pleads Guilty to Price…

COVID-19 Accredited Webcourse Now Available

On Monday, March 30, 2020, Rockpointe and the Potomac Center for Medical Center, in collaboration with MedChi, published an on-demand CME/CPE/CNE accredited web course entitled, “COVID-19 in the…

CMS Publishes COV-19 FAQs for Medicaid and CHIP

The Centers for Medicare and Medicaid Services (“CMS”) recently released a Frequently Asked Questions “FAQs” document, to provide guidance to state Medicaid and Children’s Health Insurance Program…

FDA Halts United States Inspections

On March 18, 2020, the United States Food and Drug Administration (FDA) announced that it was suspending routine surveillance audits in the United States. This follows the decision made by the Agency…

IHME Creates COVID-19 Projection Tool

The Institution for Health Metrics and Evaluation (IHME) is an independent global health research center at the University of Washington that focuses on providing “rigorous and comparable measurement…

CMS Provides Flexibility to Open Payments Reporting Deadline

On March 25th, the Centers for Medicare & Medicaid Services (CMS) recognized that the COVID-19 pandemic may impact the ability for pharmaceutical and device manufactures plus distributors to…

COVID-19 Physician Groups Call out for More Supplies

COVID-19 is drawing responses from all areas of the healthcare community. This is especially true among health industry trade groups and physician organizations. Between March 17 and 19, groups issued…

Insys Executives Sentenced

In an update to the shady and criminal dealings that went on within Insys Therapeutics, two additional former executives were recently sentenced to more than two years in federal prison for their part…

Mallinckrodt Acthar® Update

Readers may remember the lawsuit that Mallinckrodt PLC subsidiary, Mallinckrodt ARD LLC, filed against the United States Department of Health and Human Services (HHS) and the Centers for Medicare and…

Pharma and Private Industry Have a Role to Play in COVID-19

David Shaywitz, a physician-scientist and founder of Astounding HealthTech, recently wrote an article about the critical private partnership between the government and the biopharmaceutical industry…

Governor Responses to COVID-19

On March 19, 2020, Maryland Governor Larry Hogan, the chair of the National Governors Association, issued a press release on behalf of the nation's governors. In the press release, Governor Hogan…

OPDP Issues Warning Letter to Outlook Pharma Over Sponsored Link

On February 21, 2020, the US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued a Warning Letter to Outlook Pharmaceuticals in reference to Outlook’s marketing…